居家医院中多重耐药菌感染的治疗。
Treatment of infections caused by multi-resistant microorganisms in hospital at home units.
机构信息
Manuel Mirón-Rubio, Unidad de Hospitalización a Domicilio. Hospital Universitario de Torrejón. Spain.
出版信息
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):18-21. doi: 10.37201/req/s01.05.2021. Epub 2021 Sep 30.
Abstract
Hospital at home units allow the treatment of moderate and severe infections by administering intravenous antibiotics to patients who would otherwise have to remain hospitalised. Increasing antibiotic resistance adds an element of difficulty to outpatient treatment of infections because multiple daily doses of antimicrobials or combinations of antimicrobials are sometimes required. This manuscript discusses some of the challenges of outpatient management of infections with multidrug-resistant microorganisms and shows the main antibiotic resistances and the outcomes of treatment of these infections in Spanish home hospitalisation units.
摘要
家庭医院病房可以为那些原本需要住院治疗的中度和重度感染患者提供静脉内抗生素治疗。抗生素耐药性的增加为感染的门诊治疗增加了难度，因为有时需要每日多次给予抗菌药物或联合使用抗菌药物。本文讨论了门诊管理多重耐药微生物感染的一些挑战，并展示了西班牙家庭住院病房中这些感染的主要抗生素耐药性和治疗结果。
相似文献
1
Treatment of infections caused by multi-resistant microorganisms in hospital at home units.
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):18-21. doi: 10.37201/req/s01.05.2021. Epub 2021 Sep 30.
2
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.
Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1125-33. doi: 10.1007/s10096-015-2330-0. Epub 2015 Feb 6.
3
Usefulness of Hospital at Home in nosocomial infections: advantages and limitations.
Rev Esp Quimioter. 2017 Sep;30 Suppl 1:61-65.
4
Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
Curr Drug Metab. 2019;20(9):720-741. doi: 10.2174/1389200220666190806142835.
5
[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33.
6
Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Int J Environ Res Public Health. 2020 Sep 23;17(19):6943. doi: 10.3390/ijerph17196943.
7
Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis.
Microb Pathog. 2023 Jun;179:106090. doi: 10.1016/j.micpath.2023.106090. Epub 2023 Mar 31.
8
Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
Clin Chim Acta. 2015 Dec 7;451(Pt A):71-7. doi: 10.1016/j.cca.2015.02.038. Epub 2015 Mar 4.
9
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision.
Expert Rev Anti Infect Ther. 2022 Oct;20(10):1309-1332. doi: 10.1080/14787210.2022.2122442. Epub 2022 Sep 28.
10
Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
BMJ Open. 2016 Nov 3;6(11):e012675. doi: 10.1136/bmjopen-2016-012675.
引用本文的文献
1
Analysis of the Frequency, Antibiotic Susceptibility, and Related Genes among Foodborne Pathogenic Bacteria Isolated from Hospital Refrigerators in Tehran, Iran.
Iran J Public Health. 2024 Mar;53(3):680-690. doi: 10.18502/ijph.v53i3.15150.
本文引用的文献
1
Antimicrobial management in community acquired pneumonia in hospital at home: Is there room for improvement?
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jun-Jul;39(6):271-275. doi: 10.1016/j.eimce.2021.04.005. Epub 2021 May 4.
2
Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting.
Rev Esp Quimioter. 2021 Jun;34(3):200-206. doi: 10.37201/req/122.2020. Epub 2021 Mar 16.
3
Plasma concentrations resulting from continuous infusion of meropenem in a community-based outpatient program: A case series.
Am J Health Syst Pharm. 2020 Dec 4;77(24):2074-2080. doi: 10.1093/ajhp/zxaa319.
4
Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates.
PLoS One. 2020 Nov 18;15(11):e0241595. doi: 10.1371/journal.pone.0241595. eCollection 2020.
5
Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.
Eur J Hosp Pharm. 2020 Mar;27(2):65-72. doi: 10.1136/ejhpharm-2019-001875. Epub 2019 Jun 20.
6
Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration.
Open Forum Infect Dis. 2019 Nov 19;6(12):ofz496. doi: 10.1093/ofid/ofz496. eCollection 2019 Dec.
7
Quality Indicators for Appropriate Outpatient Parenteral Antimicrobial Therapy in Adults: A Systematic Review and RAND-modified Delphi Procedure.
Clin Infect Dis. 2020 Mar 3;70(6):1075-1082. doi: 10.1093/cid/ciz362.
8
Executive summary of outpatient parenteral antimicrobial therapy: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society.
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Jun-Jul;37(6):405-409. doi: 10.1016/j.eimc.2018.03.012. Epub 2018 May 18.
9
Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry.
Future Microbiol. 2016;11(3):375-90. doi: 10.2217/fmb.15.141. Epub 2016 Mar 14.
10
Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
Eur J Intern Med. 2015 Mar;26(2):131-6. doi: 10.1016/j.ejim.2015.01.001. Epub 2015 Jan 14.
Zotero 插件